Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Myelodysplastic Syndromes 48Leukemia 35Lymphoma 24Leukemia, Lymphocytic, Chronic, B-Cell 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Lymphoma, Non-Hodgkin 21Hodgkin Disease 21Multiple Myeloma 18Hematologic Neoplasms 18Leukemia, Myelomonocytic, Chronic 11Leukemia, Biphenotypic, Acute 9Graft vs Host Disease 9Myeloproliferative Disorders 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Juvenile 7Neoplasms, Plasma Cell 6Lymphoma, Follicular 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Accelerated Phase 4Hemoglobinuria, Paroxysmal 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4Recurrence 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

Melphalan 4fludarabine 3fludarabine phosphate 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Cyclophosphamide 2Busulfan 2Bone Marrow Transplantation 2Alemtuzumab 2venetoclax 1spartalizumab 1sabatolimab 1ruxolitinib 1lintuzumab 1filanesib 1Stem Cell Transplantation 1Sertraline 1Sampling Studies 1Metformin 1Lenalidomide 1Decitabine 1Clofarabine 1CPI-0610 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Preleukemia × Stem Cell Transplantation × Other hematologic neoplasm × Clear all
NCT00943592 2014-02-27

Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

University of Chicago

Phase 1/2 Completed
82 enrolled 12 charts
Other hematologic neoplasm

Leukemia, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡